Sonoma Pharmaceuticals Inc (SNOA)

NASDAQ
3.590
-0.110(-2.97%)
After Hours
3.570
-0.020(-0.557%)
- Real-time Data
  • Volume:
    30,537
  • Bid/Ask:
    3.550/4.370
  • Day's Range:
    3.525 - 3.840

SNOA Overview

Prev. Close
3.7
Day's Range
3.525-3.84
Revenue
14.52M
Open
3.69
52 wk Range
3.28-13.36
EPS
-2.52
Volume
30,537
Market Cap
11.12M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
198,060
P/E Ratio
-
Beta
0.79
1-Year Change
-56.06%
Shares Outstanding
3,097,674
Next Earnings Date
Feb 10, 2022
What is your sentiment on Sonoma Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Sonoma Pharmaceuticals Inc Company Profile

Employees
15

Sonoma Pharmaceuticals, Inc. is engaged in developing and producing hypochlorous acid (HOCl) products for a range of applications, including wound care, animal health care, eye care, oral care and dermatological conditions. The Company's product offerings include Epicyn Antimicrobial Facial Cleanser, Levicyn Antimicrobial Dermal Spray, Levicyn Antipruritic Gel, Levicyn Antipruritic Spray Gel, Celacyn Scar Management Gel and Sebuderm Topical Gel. Its products are primarily targeted at the treatment of acne, the management of scars and atopic dermatitis. It also has its office dispense products, such as Lasercyn Dermal Spray, Lasercyn Post Procedure Gel and Regenacyn Advanced Scar Management. The Company sells its products either directly or via partners in approximately 54 countries across the world. Its subsidiaries include Aquamed Technologies, Inc., Oculus Technologies of Mexico, S.A. de C.V. and Sonoma Pharmaceuticals Netherlands B.V.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • bullish
    0
    • Cheapest nasdaq stock
      1
      • Whos encourage this shares and why?
        0
        • Hi
          0
          • i see they have products already manufactured. what do you think is the futute of this stock and company?
            0
            • of course
              0
          • https://seekingalpha.com/news/3643562-sonoma-pharmaplus-35-on-crown-laboratories-partnership
            0
            • is there a delay to announce the 2nd Quarter earning.
              0
              • What's going on?
                0
                • is this a vaccine?
                  0
                  • No, it is a disinfectant.
                    0
                  • 0
                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.